Smart Diabetes Management Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

The smart diabetes management market was valued at USD 6.04 Billion in 2024, driven by the rising prevalence of diabetes and the advancements in diabetes management technology across the 8 major markets. It is expected to grow at a CAGR of 14.80% during the forecast period of 2025-2034, with the values likely to reach USD 24.01 Billion by 2034.

Smart Diabetes Management Market Overview

Smart diabetes management leverages technology to help diabetes patients manage their condition and improve the quality of their lives. The market is driven by the rising prevalence of diabetes and a growing trend towards self-diabetes management. The rising innovation and diversification in diabetes care products are expected to favor market growth in the coming years. Moreover, the increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions, is poised to catalyze market expansion in the forecast period.

Smart Diabetes Management Market Growth Drivers

Increasing Prevalence of Diabetes Drives Market Growth

Recent data suggests that more than half a billion people in the world are suffering from diabetes. The global prevalence of the disease is reported to be 6.1%, with diabetes ranking as one of the top 10 leading causes of disability and death. Further, it is projected that the number of people with diabetes is likely to more than double (1.3 billion) in the next 30 years, reflecting the need for smart diabetes management tools like continuous glucose monitors (CGMs), smart insulin pumps, and smart insulin pens for improved control of the condition. Thus, the rising burden of diabetes is expected to fuel the market growth.

Smart Diabetes Management Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rise in Regulatory Approvals to Affect the Market Landscape Significantly

In August 2024, the Food and Drug Administration (FDA) approved the Simplera continuous glucose monitor (CGM), a disposable, easy-to-use, all-in-one CGM developed by Medtronic. The Simplera platform features a discreet and simplified design and includes Simplera CGM and Simplera Sync Sensor. The rise in such regulatory approvals of innovative devices is projected to support market growth.

Launch of Innovative Products Poised to Augment Smart Diabetes Management Market Demand

In February 2024, Kakao Healthcare, a major provider of virtual healthcare services and digital transformation solutions for hospitals, introduced an AI-powered mobile diabetes management app called PASTA (Personalised, Accessible, Supportive, Tech-enabled, and Affordable). The mHealth app is designed to link with two CGM devices: Dexcom's G7 and i-SENS, Inc.'s CareSens Air. By the second quarter, the app is also expected to pair with the Mallya smart cap for insulin pens. The surge in the launch of such advanced diabetes management apps is poised to augment the market demand in the coming years.

Growing Patient Awareness to Elevate the Smart Diabetes Management Market Value

A significant market trend is the growing awareness about the benefits of smart diabetes management devices as a result of public health initiatives and awareness campaigns. This is prompting diabetes patients to use more advanced diabetes management tools such as real-time glucose monitoring systems to efficiently track their condition.

Increasing Aging Population to Boost Smart Diabetes Management Market Size

The aging population is another key driver of the market, boosting the demand for smart diabetes management tools that allow for easy monitoring and medication adjustments for this age group. Devices that feature simplified interfaces such as easy-to-read displays and voice-activated systems are gaining popularity among elderly patients, which is set to influence the market landscape in the forecast period.

Smart Diabetes Management Market Segmentation

Market Breakup by Devices

• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Smart Glucose Meters
• Closed Loop Systems

Market Breakup by Device Type

• Handheld
• Wearable

Market Breakup by Application

• Type 1 Diabetes
• Type 2 Diabetes

Market Breakup by End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Independent Pharmacies
• Online Pharmacies
• Others

Market Breakup by Region

• United States
• EU-4 and the United Kingdom
• Germany
• France
• Italy
• Spain
• Japan
• India

Smart Diabetes Management Market Share

The Devices Segment is Projected to Hold Substantial Market Share

Based on the devices, the market is segmented into continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, smart glucose meters, and closed-loop systems. The continuous glucose monitoring (CGM) segment holds a high market value due to its ability to track glucose levels over time and provide real-time data on fluctuations in glucose levels. On the other hand, smart insulin pens like NovoPen® 6 and NovoPen Echo® Plus help in automatically tracking and recording insulin dosing information with each injection.

Smart Diabetes Management Market Analysis by Region

The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States leads the market share which can be attributed to the strong presence of key players boasting a diversified product portfolio and the high demand for technologically advanced treatments to manage diabetes. The market in the region is also influenced by the growing trend towards the self-management of the disease and the preference for personalized diabetes management solutions.

Leading Players in the Smart Diabetes Management Market

The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Medtronic plc

This American-Irish medical device company is one of the leading players in the market, known for manufacturing and marketing diagnostic and therapeutic medical products. One of the key products of the company is Guardian Connect, a smart continuous glucose monitoring (CGM) system, that can alert diabetes patients 60 minutes in advance in response to high or low blood glucose levels.

Abbott Laboratories

Abbott Laboratories, headquartered in Illinois, United States, contributes significantly towards the advancement of diabetes care. Abbott’s FreeStyle Libre continuous glucose monitoring system is a popular product that is indicated for measuring interstitial fluid glucose levels in individuals with diabetes mellitus who are 4 years of age or above.

Dexcom, Inc

Dexcom, headquartered in California, United States, is a leading company that manufactures and distributes continuous glucose monitoring systems for diabetes management. The company boasts manufacturing facilities in Arizona, Batu Kawan (Malaysia), and Mesa.

Roche Diabetes Care

Roche Diabetes Care, a global leader in diabetes management and services, specializes in the development of blood glucose monitoring systems. Its Accu-Check brand offers innovative solutions for diabetes patients including data management systems, blood glucose meters, and education programs.

Other key players in the market include Insulet Corporation, Tandem Diabetes Care, Inc., Eli Lilly and Company, Novo Nordisk A/S, Ascensia Diabetes Care Holdings AG, and Johnson & Johnson (LifeScan, Inc.).

Key Questions Answered in the Smart Diabetes Management Market Report

• What was the smart diabetes management market value in 2024?
• What is the smart diabetes management market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is market segmentation based on devices?
• What is the market breakup based on device type?
• What is the market breakup by application?
• Who are the major end users in the market?
• What are the major factors aiding the smart diabetes management market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How do the prevalence and incidence of diabetes affect the market landscape?
• What are the major smart diabetes management market trends?
• How does the emergence of mobile health applications impact the market size?
• Which devices will dominate the market share?
• Which device type is expected to have a high market value in the coming years?
• Which application will experience the highest demand in the market segment?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the smart diabetes management market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.